IP Library Granted Patent US 10,143,196
Granted Patent B2
US 10,143,196 · App. 13/809,644 · Granted Dec 4, 2018

Antibacterial medical product and method for producing same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,143,196
App. No.
13/809,644
Granted
Dec 4, 2018
Kind
B2
Abstract

The present invention relates to a medical product, comprising an antibacterial hard material coating, which is applied to a main body and which comprises biocide. Said hard material coating includes at least one inner layer and one outer layer, wherein the biocide concentration in the outer layer is substantially constant and greater than the biocide concentration in the inner layer and the biocide concentration in the inner layer is greater than or equal to 0.2 at %.

Claims (12)

1. Medical product with an antibacterial hard material coating applied to a main body and which comprises a non-organic biocide, the hard material coating including at least one inner layer with a thickness (d 1 ) of at least 0.2 μm and one outer layer with a thickness (d 2 ) of at least 0.5 μm, wherein the inner layer is arranged between the outer layer and the main body and the outer layer contains a biocide concentration (bcI) of 2 at % to 15 at %, wherein bcI is substantially constant throughout the outer layer, wherein:

the inner layer has a biocide concentration averaged over at least 20 nm depth with a maximum value (bcII), wherein bcII is greater than or equal to 0.2 at % and less than bcI,

an intermediate layer between the inner layer and the outer layer, wherein the intermediate layer has a biocide concentration (bcIII) that is greater than bcI, and

the hard material coating includes one or more of TiN, TiAlN, AlTiN, CrN, WC/C or a-C:H.

2. Medical product according to claim 1 , characterized in that between the inner layer and the main body at least one bonding layer and/or anti-wear protection layer and/or hard material layer is arranged essentially without biocide.

3. Medical product according to claim 2 , characterized in that between the inner layer and the main body or between the inner layer and the at least one bonding layer there is at least one anti-wear protection layer that has a hardness of equal to or greater than 1500 HV to protect the overlaid layers.

4. Medical product according to claim 1 characterized in that the biocide is silver or the combination of biocides comprises silver.

5. Medical product with an antibacterial hard material coating applied to a main body and which comprises a non-organic biocide, the hard material coating including at least one inner layer with a thickness (d 1 ) of at least 0.2 μm and one outer layer with a thickness (d 2 ) of at least 0.5 μm, wherein the inner layer is arranged between the outer layer and the main body and the outer layer contains a biocide concentration (bcI) of 2 at % to 15 at %, the concentration being substantially constant throughout the outer layer, wherein:

the inner layer has a biocide concentration averaged over at least 20 nm depth with a maximum value (bcII), wherein bcII is greater than or equal to 0.2 at % and less than bcI, and

the hard material includes one or more of TiN, TiAlN, AlTiN, CrN, WC/C or a-C:H, and

between the inner layer and the main body there is at least one anti-wear protection layer that has a hardness of equal to or greater than 1500 HV, and

between the inner layer and the outer layer there is at least one intermediate layer with a biocide concentration (bcIII), where bcIII is greater than bcI.

Assignments (4)
CHANGE OF NAME Recorded Sep 7, 2018
From: OERLIKON SURFACE SOLUTIONS AG, TRUBBACH
To: OERLIKON SURFACE SOLUTIONS AG, PFAFFIKON
Reel/Frame 046815/0043 →
CHANGE OF NAME Recorded Sep 5, 2018
From: OERLIKON TRADING AG, TRUEBBACH
To: OERLIKON SURFACE SOLUTIONS AG, TRUBBACH
Reel/Frame 046787/0285 →
CHANGE OF ADDRESS Recorded Jan 21, 2014
From: OERLIKON TRADING AG, TRUEBBACH
To: OERLIKON TRADING AG, TRUEBBACH
Reel/Frame 032094/0614 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2013
From: COLMENARES MORA, CARMEN LEONOR; MUELLER, ARND; JANSSEN, ALBERT PETER GERHARD
To: OERLIKON TRADING AG, TRUBBACH
Reel/Frame 030435/0400 →
Cited By (1)
US 12,601,049